Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
Become a Member | Sign in
Home>News>This Article

Dr. Attila Endre Pavlath Joins the Board of Directors of ComInnex Inc.

Published: Saturday, August 09, 2014
Last Updated: Saturday, August 09, 2014
Bookmark and Share
Dr. Pavlath’s achievements recognized by ACS at the 248th National Meeting & Exposition in San Francisco.

ComInnex, Inc. has announced that Dr. Attila Endre Pavlath joined its Board of Directors.

Dr. Attila Endre Pavlath, a well known scientist and former ACS president will bring his strategic experience into the governing body of ComInnex. Dr. Pavlath’s 6 decades of achievements are also recognized by the American Chemical Society at a dedicated session at the ACS 248th National Meeting & Exposition in San Francisco on August 12th , 2014 at 8:00 am. (

ComInnex is a chemistry and medicinal chemistry service organization with strong interest and background in the development of chemical technologies that enables its partners to access novel chemical space and intellectual property. Its current technology innovation platform focuses on the development of synthetic tools towards novel non-flat fragment-like and lead-like molecules for lead identification and medicinal chemistry. To this end the company recently introduced its Smartdiversity™ platform that rapidly creates new IP space for medicinal chemistry.

ComInnex technologies enable the company to penetrate chemical space not easily reachable by traditional laboratory techniques and develop unique and patentable molecular frameworks of high value for the pharmaceutical, agrochemical and chemical industries.

Dr. Ferenc Darvas, President and Chairman of ComInnex commented that “We are proud that Dr. Pavlath joins our Governing Board. We believe that his experience and significant
achievements will be a great asset for the company and will help expand our value added innovative portfolio of offerings.”

Dr. Pavlath added that “I am glad that I could join such a dynamic and innovative company like ComInnex at the governing level and join the experienced industry veterans in the management and Board level such as Dr. Ferenc Darvas, Dr. Gergely Makara and Dr. Laszlo Urge. I believe that together we will create and execute a strategy that will benefit customers significantly and keep ComInnex in the forefront of innovation.”

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
Drug May Prevent Life-Threatening Muscle Loss in Advanced Cancers
New data describes how an experimental drug can stop life-threatening muscle wasting (cachexia) associated with advanced cancers and restore muscle health.
Chemical Design Made Easier
Rice University scientists prepare elusive organocatalysts for drug and fine chemical synthesis.
Nanocarriers May Carry New Hope for Brain Cancer Therapy
Berkeley lab researchers develop nanoparticles that can carry therapeutics across the brain blood barrier.
Potential Persistent Tuberculosis Treatment
Researchers have discovered several first-in-class compounds that target hidden TB infections by attacking a critical process the bacteria use to survive in the hostile environment of the lungs.
Shedding Light on “Dark” Cellular Receptors
UNC and UCSF labs create a new research tool to find homes for two orphan cell-surface receptors, a crucial step toward finding better therapeutics and causes of drug side effects.
Giant Molecules Inhibit Ebola Infection
European researchers have designed a "giant" molecule formed by thirteen fullerenes covered by carbohydrates which, by blocking this receptor, are able to inhibit the cell infection by an artificial ebola virus model.
First Therapy Appearing to Reverse Decline in Parkinson’s
An FDA-approved drug for leukemia improved cognition, motor skills and non-motor function in patients with Parkinson’s disease and Lewy body dementia in a small clinical trial, say researchers at Georgetown University Medical Center (GUMC).
Fighting Pain with Ketamine
Researchers at the Texas A&M Health Science Center are using ketamine, a drug that already exists as an anesthetic, to treat pain.
Possible New Treatment for Neurodegenerative Diseases Found
Researchers at the University of Liverpool have found that a well-established anti-epileptic drug could also be used as a treatment for neurodegenerative diseases.
Breast Cancer Drug Beats Superbug
Tamoxifen helps white blood cells clear multidrug-resistant bacteria in lab and mouse studies.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos